We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

William I. Intner


William I. Intner

William Intner has a robust practice in corporate, securities, and general business law, helping companies with their most important strategic transactions and disclosure and governance issues.

While most of his work is focused in the life sciences, healthcare, and education sectors, his active clients range from large, international corporations to smaller growth companies across many industries, including technology and manufacturing. Having represented companies from their founding through stages of investments, the initial public offering process and ultimate exit transactions, he has a keen understanding of the lifecycle of a company, and how to navigate growth and change.

William's practice is relationship based. Having served in the role of outside general counsel to many of his clients, he understands the importance of having a deep understanding of his clients' business and bringing a practical approach to the table.

In his securities and capital markets practice, William works with clients on their debt and equity offerings (public and private), initial public offerings, and venture capital financings. In the transactional area, William represents privately and publicly held corporations, private equity investors, and universities in connection with a broad range of corporate and transactional matters, such as mergers, acquisitions, product divestitures, strategic affiliations, joint ventures, and other complex corporate arrangements. In the disclosure and governance area, William provides counsel to public companies on U.S. securities laws, including general disclosure requirements and periodic reporting obligations, as well as on complex governance matters.

Representative experience

TESARO, Inc. on its initial public offering, follow-on equity offerings, and convertible note offering.

LabCorp on US$5.8bn of senior debt offerings, including in connection with the US$6.2bn acquisition of Covance, Inc.

Advised the board of a private college in connection with the consideration of the closing of the college.

Advised a public university on the development of an international pathway program with a third-party provider.

Advised several research universities on the corporate structure for the development of international programs.

Education and admissions


  • J.D., Stanford Law School, 2000
  • B.A., magna cum laude, Connecticut College, 1996

Bar admissions and qualifications

  • Maryland


M&A/Corporate and Commercial: Corporate Governance

Legal 500 US



Chambers USA

Loading data